Processa Acquires Vidya with $200 Million Financing
Processa Pharmaceuticals acquired Vidya Discovery stock-for-stock and announced a concurrent private placement expected to generate approximately $200 million in gross proceeds. The combined company gains VT-7208, a covalent, CNS-penetrant BTK inhibitor planned for Phase…
